Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases

Recruiting

• Conditions: Neuro-co-cardiological Diseases; Vascular Lesion; Post-cardiac Surgery Cerebrovascular Diseases

• Registration Number: NCT07012668
• Lead Sponsor: Beijing Anzhen Hospital

Brief Summary

The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-09-19
• Status Verified: 2025-06
• Study First Submitted: 2025-06-01
• Study First Submitted QC: 2025-06-01
• Last Update Submitted: 2025-06-09
• Study First Posted: 2025-06-10
• Last Update Posted: 2025-06-12
• Primary Completion: 2027-09-19
• Study Completion: 2027-09-19

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

1. Age ≥18 years;
2. Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.

Exclusion Criteria

1. The expected survival is less than 1 years;
2. Simultaneously merge other serious diseases;

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Modified Rankin Scale Score	90±7 days	Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.

Secondary Outcome Measures

Name	Time	Method
Short-term complications	90±7 days
Long-term complications	365±30 days
Rate of cardiovascular and cerebrovascular events	365±30 days
Modified Rankin Scale Score	365±30 days	Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.
Perioperative complication rate	30±7 days

Trial Locations

Locations (1)

Beijing Anzhen Hospital; 🇨🇳 Beijing, China